Lifestyle factors, environmental toxins and nutrient deficiencies are having a negative impact on our thyroid function, and this is leading to a growing epidemic of thyroid disease. Without adequate levels of key minerals, like selenium, which is a required co-factor for enzymes that convert the inactive hormone T4 to the more active T3 hormone, the body cannot produce enough thyroid hormone, which affects virtually all bodily functions, from metabolism to reproduction.
A detailed report by Transparency Market Research sheds more light on the potential of this market. The report states that thyroid gland disorders, such as hypothyroidism, hyperthyroidism and thyroid nodules affect between five percent and 10 percent of the population globally.
While the actual cause of thyroid disease is not known, the growing prevalence may be linked to increasing incidence of autoimmune diseases and lifestyle factors, like environmental toxins, and nutritional deficiencies. Beyond selenium deficiency, low iodine is also linked to thyroid problems and is now an increasing concern worldwide, even in industrialized nations like the United States. Iodine is necessary for synthesis of thyroid hormones, as an important component of both thyroxine (T4) and triiodothyronine (T3). Research also shows that iodine acts as an antioxidant, supporting a healthy thyroid gland and protecting various tissues such as mammary tissues, eyes and the gastrointestinal lining.
Given these statistics, it is not surprising that the global thyroid gland disorders treatment market is on the rise. Sales of these treatments reached $1,954.7 million in 2016 and are predicted to hit $2,609.9 million by 2025, with a CAGR of 3.3 percent during that time period, according to the Transparency Market Research report. North America is the largest market for treatment of thyroid gland disorders, but the Asia Pacific market is likely to see the fastest growth in terms of drugs for these treatments.